Designation of a Class of Employees for Addition to the Special Exposure Cohort, 26299-26300 [2011-11094]

Download as PDF Federal Register / Vol. 76, No. 88 / Friday, May 6, 2011 / Notices emcdonald on DSK2BSOYB1PROD with NOTICES well as one clerical or administrative staff member, at $15 per hour, require such training, for a total burden of 39,804 hours (19,902 funeral homes × 2 hours total per establishment), and $925,443 [($35 + $23 + $20 + $15) × c hour per employee × 19,902 funeral homes]. The total labor cost of the three disclosure requirements imposed by the Funeral Rule is $3,139,620 ($1,343,385 + $90,545 + $1,705,690). The total labor cost for recordkeeping is $298,530. The total labor cost for disclosures, recordkeeping, and training is $4,363,593 ($3,139,620 for disclosures + $298,530 for recordkeeping + $925,443 for training). Capital or other non-labor costs: The Rule imposes minimal capital costs and no current start-up costs. The Rule first took effect in 1984 and the revised Rule took effect in 1994, so funeral providers should already have in place necessary equipment to carry out tasks associated with Rule compliance. Moreover, most funeral homes already have access, for other business purposes, to the ordinary office equipment needed for compliance, so the Rule likely imposes minimal additional capital expense. Compliance with the Rule, however, does entail some expense to funeral providers for printing and duplication of required disclosures. Assuming that one copy of the GPL is provided to consumers for each funeral or cremation conducted, at $.25 per copy, as required by the Rule,14 this would amount to 2,436,682 copies per year at a cumulative industry cost of $624,171 (2,436,682 funerals per year15 × $.25 per price list). In addition, the funeral providers that furnish consumers with an SFGSS solely because of the Rule’s mandate will incur additional printing and copying costs. Assuming that those 2,587 providers (19,902 funeral providers × 13%) use the standard twopage form SFGSS shown in the compliance guide, at twenty-five cents per copy, at an average of twenty funerals per year, the added cost burden would be $12,935 (2,587 providers × 20 funerals per year × $.25). Thus, only’’ found in the 2010 NFDA Member Compensation Survey. See https://www.nfda.org/ news-a-events/all-press-releases/2289-nfdareleases-results-of-2010-member-compensationsurvey.html. Hourly rates were then determined by dividing those salaries by an assumed 2,000 hour work year, then rounded. 14 Although copies of the CPL and OBCPL must be shown to consumers, the Rule does not require that they be given to consumers. Thus, the cost of printing a single copy of these two disclosures to show consumers is de minimis, and is not included in this estimate of printing costs. 15 See note 2 and accompanying text. VerDate Mar<15>2010 17:26 May 05, 2011 Jkt 223001 estimated non-labor costs total $637,106. Request for Comment You can file a comment online or on paper. For the Commission to consider your comment, we must receive it on or before July 5, 2011. Write ‘‘Paperwork Comment: FTC File No. P084401’’ on your comment. Your comment— including your name and your state— will be placed on the public record of this proceeding, including, to the extent practicable, on the public Commission Web site, at https://www.ftc.gov/os/ publiccomments.shtm. As a matter of discretion, the Commission tries to remove individuals’ home contact information from comments before placing them on the Commission Web site. Because your comment will be made public, you are solely responsible for making sure that your comment doesn’t include any sensitive personal information, like anyone’s Social Security number, date of birth, driver’s license number or other state identification number or foreign country equivalent, passport number, financial account number, or credit or debit card number. You are also solely responsible for making sure that your comment doesn’t include any sensitive health information, like medical records or other individually identifiable health information. In addition, don’t include any ‘‘[t]rade secret or any commercial or financial information which is obtained from any person and which is privileged or confidential * * *, ’’ as provided in Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2). If you want the Commission to give your comment confidential treatment, you must file it in paper form, with a request for confidential treatment, and you have to follow the procedure explained in FTC Rule 4.9(c), 16 CFR 4.9(c). Your comment will be kept confidential only if the FTC General Counsel, in his or her sole discretion, grants your request in accordance with the law and the public interest. Postal mail addressed to the Commission is subject to delay due to heightened security screening. As a result, we encourage you to submit your comments online, or to send them to the Commission by courier or overnight service. To make sure that the Commission considers your online comment, you must file it at https:// ftcpublic.commentworks.com/ftc/ funeralrulepra, by following the instructions on the web-based form. If this Notice appears at https:// www.regulations.gov/#!home, you also PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 26299 may file a comment through that Web site. If you file your comment on paper, write ‘‘Paperwork Comment: FTC File No. P084401’’ on your comment and on the envelope, and mail or deliver it to the following address: Federal Trade Commission, Office of the Secretary, Room H–113 (Annex J), 600 Pennsylvania Avenue, NW., Washington, DC 20580. If possible, submit your paper comment to the Commission by courier or overnight service. Visit the Commission Web site at https://www.ftc.gov to read this Notice and the news release describing it. The FTC Act and other laws that the Commission administers permit the collection of public comments to consider and use in this proceeding as appropriate. The Commission will consider all timely and responsive public comments that it receives on or before July 5, 2011. You can find more information, including routine uses permitted by the Privacy Act, in the Commission’s privacy policy, at https:// www.ftc.gov/ftc/privacy.htm. The FTC invites comments on: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Willard K. Tom, General Counsel. [FR Doc. 2011–11053 Filed 5–5–11; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Designation of a Class of Employees for Addition to the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: E:\FR\FM\06MYN1.SGM 06MYN1 26300 Federal Register / Vol. 76, No. 88 / Friday, May 6, 2011 / Notices HHS gives notice of a decision to designate a class of employees from the Linde Ceramics Plant in Tonawanda, New York, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On April 21, 2011, the Secretary of HHS designated the following class of employees as an addition to the SEC: SUMMARY: All Atomic Weapons Employees who worked at the Linde Ceramics Plant in Tonawanda, New York, from January 1, 1954 through December 31, 1969, for a number of work days aggregating at least 250 work days, occurring either solely under this employment, or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort. This designation will become effective on May 21, 2011, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 877– 222–7570. Information requests can also be submitted by e-mail to DCAS@CDC.GOV. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 2011–11094 Filed 5–5–11; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Blood Safety and Availability Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. ACTION: Notice. emcdonald on DSK2BSOYB1PROD with NOTICES AGENCY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services (HHS) is hereby giving notice that the Advisory Committee on Blood Safety and Availability (ACBSA) will hold a meeting. The meeting will be open to the public. SUMMARY: VerDate Mar<15>2010 17:26 May 05, 2011 Jkt 223001 The meeting will take place Tuesday, June 7, and Wednesday June 8, 2011, from 8:30 a.m. to 5 p.m. ADDRESSES: National Institute of Health, Building 31, Conference Room 6, Bethesda, MD 20892. FOR FURTHER INFORMATION CONTACT: Mr. James Berger, Associate Public Health Advisor for Blood, Organ and Tissue Safety, Office of the Assistant Secretary for Health, Department of Health and Human Services, 1101 Wootton Parkway, Suite 250, Rockville, MD 20852, (240) 453–8803, Fax (240) 453– 8456, e-mail ACBSA@hhs.gov. SUPPLEMENTARY INFORMATION: The ACBSA shall provide advice to the Secretary through the Assistant Secretary for Health. The Committee shall advise on a range of policy issues to include: (1) Definition of public health parameters around safety and availability of the blood supply and blood products, (2) broad public health, ethical and legal issues related to transfusion, and transplantation safety, and (3) the implications for safety and availability of various economic factors affecting product cost and supply. In keeping with its established mission, the Committee will also be asked to review and provide comments to the Department on two World Health Assembly (WHA) resolutions related to transfusion, and transplantation safety. https://apps.who.int/gb/ebwha/pdf_files/ WHA63/A63_R22-en.pdf On June 7, 2011, the Committee will be asked to review the WHA 63.22 on human organ and tissue transplantation and if appropriate, make recommendations on areas of enhanced safety. Specifically areas of collecting data including adverse events and reactions on the practices, safety, quality, efficacy, epidemiology and ethics of donations and transplantation will be considered as it relates to safety. Concerns for a globally consistent coding system for human cells, tissues and organs to facilitate national and international traceability of materials of human origin for transplantation will be solicited. In addition, the Committee will be asked for comments or recommendations on developing and promoting international best practices. On June 8, 2011, the Committee will be asked to review and comment on WHA 63.12 regarding the availability, safety and quality of blood products. https://apps.who.int/gb/ebwha/pdf_files/ WHA63/A63_R12-en.pdf Specifically the Committee will be asked to review the current status of safe and rational use of blood products in patient blood management and assess the current status in the U.S. DATES: PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 In addition, the Committee will be asked to comment on the areas of safety and sustainability of providing blood and blood products that should be addressed by the Committee in future meetings. The public will have the opportunity to present their views to the Committee during a public comment session scheduled for June 7, 2011. Comments will be limited to five minutes per speaker and must be pertinent to the discussion. Pre-registration is required for participation in the public comment session. Any member of the public who would like to participate in this session is encouraged to contact the Executive Secretary at his/her earliest convenience to register for time (limited to 5 minutes) and registration must be prior to close of business on June 3, 2011. If it is not possible to provide 30 copies of the material to be distributed, then individuals are requested to provide a minimum of one (1) copy of the document(s) to be distributed prior to 11:30 a.m. Eastern Daylight Time on June 6, 2011. It is also requested that any member of the public who wishes to provide comments to the Committee utilizing electronic data projection to submit the necessary material to the Executive Secretary prior to the close of business on June 6, 2011. Electronic comments must adhere to disability accessibility guidelines (Section 508 compliance). Dated: May 3, 2011. James J. Berger, Associate Public Health Advisor for Blood, Organ and Tissue Safety. [FR Doc. 2011–11128 Filed 5–5–11; 8:45 am] BILLING CODE 4150–41–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Group on Prevention, Health Promotion, and Integrative and Public Health Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health, Office of the Surgeon General of the United States Public Health Service. ACTION: Notice. AGENCY: In accordance with Section 10(a) of the Federal Advisory Committee Act, Public Law 92–463, as amended (5 U.S.C. App.), notice is hereby given that a web meeting is scheduled to be held for the Advisory Group on Prevention, Health Promotion, and Integrative and Public Health (the ‘‘Advisory Group’’). The web meeting will be open to the public. Information about the Advisory SUMMARY: E:\FR\FM\06MYN1.SGM 06MYN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 76, Number 88 (Friday, May 6, 2011)]
[Notices]
[Pages 26299-26300]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-11094]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Designation of a Class of Employees for Addition to the Special 
Exposure Cohort

AGENCY: National Institute for Occupational Safety and Health (NIOSH), 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

[[Page 26300]]

SUMMARY: HHS gives notice of a decision to designate a class of 
employees from the Linde Ceramics Plant in Tonawanda, New York, as an 
addition to the Special Exposure Cohort (SEC) under the Energy 
Employees Occupational Illness Compensation Program Act of 2000. On 
April 21, 2011, the Secretary of HHS designated the following class of 
employees as an addition to the SEC:

    All Atomic Weapons Employees who worked at the Linde Ceramics 
Plant in Tonawanda, New York, from January 1, 1954 through December 
31, 1969, for a number of work days aggregating at least 250 work 
days, occurring either solely under this employment, or in 
combination with work days within the parameters established for one 
or more other classes of employees in the Special Exposure Cohort.

    This designation will become effective on May 21, 2011, unless 
Congress provides otherwise prior to the effective date. After this 
effective date, HHS will publish a notice in the Federal Register 
reporting the addition of this class to the SEC or the result of any 
provision by Congress regarding the decision by HHS to add the class to 
the SEC.

FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, 
Division of Compensation Analysis and Support, National Institute for 
Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46, 
Cincinnati, OH 45226, Telephone 877-222-7570. Information requests can 
also be submitted by e-mail to DCAS@CDC.GOV.

John Howard,
Director, National Institute for Occupational Safety and Health.
[FR Doc. 2011-11094 Filed 5-5-11; 8:45 am]
BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.